chr19-55157029-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000363.5(TNNI3):c.108+21G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0664 in 1,570,564 control chromosomes in the GnomAD database, including 4,000 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.051 ( 278 hom., cov: 32)
Exomes 𝑓: 0.068 ( 3722 hom. )
Consequence
TNNI3
NM_000363.5 intron
NM_000363.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.556
Genes affected
TNNI3 (HGNC:11947): (troponin I3, cardiac type) Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 19-55157029-C-T is Benign according to our data. Variant chr19-55157029-C-T is described in ClinVar as [Benign]. Clinvar id is 255944.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-55157029-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0967 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0513 AC: 7796AN: 151996Hom.: 280 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
7796
AN:
151996
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0662 AC: 12169AN: 183920 AF XY: 0.0711 show subpopulations
GnomAD2 exomes
AF:
AC:
12169
AN:
183920
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0680 AC: 96472AN: 1418450Hom.: 3722 Cov.: 33 AF XY: 0.0699 AC XY: 49041AN XY: 701526 show subpopulations
GnomAD4 exome
AF:
AC:
96472
AN:
1418450
Hom.:
Cov.:
33
AF XY:
AC XY:
49041
AN XY:
701526
Gnomad4 AFR exome
AF:
AC:
405
AN:
33190
Gnomad4 AMR exome
AF:
AC:
1377
AN:
36714
Gnomad4 ASJ exome
AF:
AC:
2373
AN:
25324
Gnomad4 EAS exome
AF:
AC:
969
AN:
38664
Gnomad4 SAS exome
AF:
AC:
8869
AN:
80882
Gnomad4 FIN exome
AF:
AC:
2942
AN:
46836
Gnomad4 NFE exome
AF:
AC:
74415
AN:
1093254
Gnomad4 Remaining exome
AF:
AC:
4414
AN:
59020
Heterozygous variant carriers
0
5541
11082
16623
22164
27705
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2790
5580
8370
11160
13950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0512 AC: 7788AN: 152114Hom.: 278 Cov.: 32 AF XY: 0.0516 AC XY: 3834AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
7788
AN:
152114
Hom.:
Cov.:
32
AF XY:
AC XY:
3834
AN XY:
74374
Gnomad4 AFR
AF:
AC:
0.0122633
AN:
0.0122633
Gnomad4 AMR
AF:
AC:
0.0411488
AN:
0.0411488
Gnomad4 ASJ
AF:
AC:
0.09683
AN:
0.09683
Gnomad4 EAS
AF:
AC:
0.0421663
AN:
0.0421663
Gnomad4 SAS
AF:
AC:
0.104193
AN:
0.104193
Gnomad4 FIN
AF:
AC:
0.0595328
AN:
0.0595328
Gnomad4 NFE
AF:
AC:
0.0687874
AN:
0.0687874
Gnomad4 OTH
AF:
AC:
0.0696682
AN:
0.0696682
Heterozygous variant carriers
0
383
766
1150
1533
1916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
216
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=11/89
disease causing
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at